Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Buys Protein Chip Maker Protometrix

NEW YORK, April 2 (GenomeWeb News) - Invitrogen has acquired protein microarray company Protometrix, the companies said today.


Invitrogen said it will offer Protometrix's first product, a yeast proteome chip, this summer. Protometrix started selling its Yeast ProtoArray chip last fall.


In addition, Invitrogen plans to introduce protein microarrays for analyzing human kinase interactions and activity in the second half of the year. Furthermore, the company intends to develop arrays for diagnostics, biomarkers and biodefense research, and testing drug interactions and side effects. Invitrogen hopes the acquisition will add $3-5 million to its revenues this year.


Protometrix, based in Branford, Conn., was founded in 2001 based on technology developed by Michael Snyder at Yale University.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.